Table 2. CMVpp52 antibodies and CMVpp52-specific T-cells in SLE patients and healthy controls.
| CMVpp52-specific (CD69) T-cells |
CMVpp52 antibodies | ||||||
|---|---|---|---|---|---|---|---|
| No. | Total | CD8+ | CD8- | IgG | IgM | IgA | |
| SLE-07 | |||||||
| SLE-09 | |||||||
| SLE-10 | |||||||
| SLE-15 | |||||||
| SLE-18 | |||||||
| SLE-20 | |||||||
| SLE-08 | |||||||
| SLE-19 | |||||||
| SLE-06 | |||||||
| SLE-26 | |||||||
| SLE-13 | |||||||
| SLE-12 | |||||||
| SLE-252 | |||||||
| SLE-17 | |||||||
| SLE-14 | |||||||
| SLE-27 | |||||||
| SLE-28 | |||||||
| HC-07 | |||||||
| HC-09 | |||||||
| HC-10 | |||||||
| HC-15 | |||||||
| HC-18 | |||||||
| HC-20 | |||||||
| HC-08 | |||||||
| HC-19 | |||||||
| HC-06 | |||||||
| HC-26 | |||||||
| HC-13 | |||||||
| HC-12 | |||||||
| HC-252 | |||||||
| HC-17 | |||||||
| HC-14 | |||||||
| HC-27 | |||||||
| HC-28 | |||||||
| Color code | |||||||
| CMVpp52-specific (CD69+) T-cells | CMVpp52 antibodies | ||||||
| >4.09% | >0.98% | <0.98% | >2*cutoff | >cutoff | <cutoff | ||